tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CGEM Stock Latest News

Cullinan Management Holds Annual Stockholders Meeting
Company AnnouncementsCullinan Management Holds Annual Stockholders Meeting
13m ago
8K
CGEM
Cullinan Therapeutics resumed with a Buy at Stifel
PremiumThe Fly
Cullinan Therapeutics resumed with a Buy at Stifel
1d ago
CGEM
Cullinan Management’s Strategic Expansion and Promising Velinotamig Results Justify Buy Rating
PremiumRatings
Cullinan Management’s Strategic Expansion and Promising Velinotamig Results Justify Buy Rating
6d ago
CGEM
Cullinan Management’s Strategic Growth and Pipeline Expansion Earns Buy Rating
PremiumRatings
Cullinan Management’s Strategic Growth and Pipeline Expansion Earns Buy Rating
6d ago
CGEM
Cullinan Management: Strategic Licensing and Financial Stability Drive Buy Rating
PremiumRatings
Cullinan Management: Strategic Licensing and Financial Stability Drive Buy Rating
8d ago
CGEM
Cullinan Management Enters Global License Agreement with Genrix
PremiumCompany AnnouncementsCullinan Management Enters Global License Agreement with Genrix
8d ago
8K
CGEM
Cullinan licenses rights to velinotamig from Genrix Bio for $20M upfront
Premium
The Fly
Cullinan licenses rights to velinotamig from Genrix Bio for $20M upfront
8d ago
CGEM
Cullinan Management’s Promising Position in Healthcare: Buy Rating Supported by Strong Phase 2b Data and Strategic Developments
Premium
Ratings
Cullinan Management’s Promising Position in Healthcare: Buy Rating Supported by Strong Phase 2b Data and Strategic Developments
10d ago
CGEM
Promising Potential of Zipalertinib Drives Buy Rating for Cullinan Management
PremiumRatings
Promising Potential of Zipalertinib Drives Buy Rating for Cullinan Management
10d ago
CGEM
Positive Outlook for Cullinan Management: Buy Rating Driven by Promising Clinical Data and Strategic Collaborations
PremiumRatings
Positive Outlook for Cullinan Management: Buy Rating Driven by Promising Clinical Data and Strategic Collaborations
10d ago
CGEM
Cullinan Therapeutics: Promising Phase 2b Data and Strategic Partnerships Drive Buy Rating
PremiumRatings
Cullinan Therapeutics: Promising Phase 2b Data and Strategic Partnerships Drive Buy Rating
16d ago
CGEM
Cullinan Therapeutics to present new results from REZILIENT1 trial
PremiumThe Fly
Cullinan Therapeutics to present new results from REZILIENT1 trial
21d ago
CGEM
Cullinan Management: Buy Rating Affirmed Amid Promising Pipeline and Financial Stability
PremiumRatingsCullinan Management: Buy Rating Affirmed Amid Promising Pipeline and Financial Stability
1M ago
CGEM
Cullinan Therapeutics price target lowered to $24 from $30 at UBS
Premium
The Fly
Cullinan Therapeutics price target lowered to $24 from $30 at UBS
1M ago
CGEM
Cullinan Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Cullinan Therapeutics Reports Q1 2025 Financial Results
1M ago
CGEM
Promising Pipeline and Strategic Initiatives Drive Buy Rating for Cullinan Management
PremiumRatings
Promising Pipeline and Strategic Initiatives Drive Buy Rating for Cullinan Management
1M ago
CGEM
Cullinan Management’s Long-Term Growth Potential: Buy Rating Despite Setbacks
PremiumRatings
Cullinan Management’s Long-Term Growth Potential: Buy Rating Despite Setbacks
1M ago
CGEM
Cullinan Management’s Strategic Advancements and Financial Stability Justify Buy Rating
PremiumRatings
Cullinan Management’s Strategic Advancements and Financial Stability Justify Buy Rating
1M ago
CGEM
Cullinan Therapeutics reports Q1 EPS (74c), consensus (81c)
PremiumThe Fly
Cullinan Therapeutics reports Q1 EPS (74c), consensus (81c)
1M ago
CGEM
Cullinan Therapeutics sees cash runway into 2028
PremiumThe FlyCullinan Therapeutics sees cash runway into 2028
1M ago
CGEM
Cullinan Management’s Strategic Expansion and Financial Stability Bolster Buy Rating for CLN-978 Development
Premium
Ratings
Cullinan Management’s Strategic Expansion and Financial Stability Bolster Buy Rating for CLN-978 Development
1M ago
CGEM
Cullinan to initiate study of CLN-978 in patients with Sjogren’s disease
Premium
The Fly
Cullinan to initiate study of CLN-978 in patients with Sjogren’s disease
1M ago
CGEM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >